Skip to main content
CORT
NASDAQ Life Sciences

Corcept Misses Q1 Revenue Estimates, Reports Loss, Boosts Full-Year Outlook

Tom Rudovsky · Reported by Reuters
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
8
Price
$46.99
Mkt Cap
$4.994B
52W Low
$28.66
52W High
$91
52W Position info
64% above low
Off High info
48% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

CORT sits 64% above its 52-week low of $28.66.

Summary

Corcept Therapeutics reported Q1 revenue of $164.90 million, significantly missing analyst estimates of $192.51 million, and posted a net loss of $31.76 million (EPS -$0.30) due to increased operating expenses related to the launch of Lifyorli. This follows a challenging 2025 marked by profitability declines. Despite the quarterly shortfall, the company raised its full-year 2026 revenue guidance to $950-$1,050 million and anticipates a return to profitability in Q2 2026. The positive outlook is driven by the recent FDA approval and launch of Lifyorli for platinum-resistant ovarian cancer, as well as strong demand for Korlym. Traders will closely monitor the sales ramp-up of Lifyorli and the company's ability to achieve its revised profitability targets.

At the time of this announcement, CORT was trading at $46.99 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $5B. The 52-week trading range was $28.66 to $91.00. This news item was assessed with neutral market sentiment and an importance score of 8 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

CORT - Latest Insights

CORT
Nov 03, 2026, 4:11 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $78.50
Real-time Price: $68.78 info
Change: -$9.72 (-12%) info
Market Cap: $7.529B info
CORT
Nov 03, 2026, 4:05 PM EST
Source: BusinessWire
Importance Score:
8
Price at Filing: $81.93
Real-time Price: $68.78 info
Change: -$13.15 (-16%) info
Market Cap: $7.529B info
CORT
Oct 26, 2026, 8:00 AM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $86.01
Real-time Price: $68.78 info
Change: -$17.23 (-20%) info
Market Cap: $7.529B info
CORT
Oct 20, 2026, 4:00 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $116.51
Real-time Price: $68.78 info
Change: -$47.72 (-41%) info
Market Cap: $7.529B info
CORT
Sep 18, 2026, 8:00 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $114.90
Real-time Price: $68.78 info
Change: -$46.12 (-40%) info
Market Cap: $7.529B info